220 related articles for article (PubMed ID: 18378447)
1. Discovery of a novel indole series of EP1 receptor antagonists by scaffold hopping.
Hall A; Billinton A; Brown SH; Chowdhury A; Giblin GM; Goldsmith P; Hurst DN; Naylor A; Patel S; Scoccitti T; Theobald PJ
Bioorg Med Chem Lett; 2008 Apr; 18(8):2684-90. PubMed ID: 18378447
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a series of acrylic acids and their derivatives as chemical leads for selective EP3 receptor antagonists.
Asada M; Obitsu T; Nagase T; Sugimoto I; Yamaura Y; Sato K; Narita M; Ohuchida S; Nakai H; Toda M
Bioorg Med Chem; 2009 Sep; 17(18):6567-82. PubMed ID: 19700331
[TBL] [Abstract][Full Text] [Related]
3. Heterocyclic 1,7-disubstituted indole sulfonamides are potent and selective human EP3 receptor antagonists.
Hategan G; Polozov AM; Zeller W; Cao H; Mishra RK; Kiselyov AS; Ramirez J; Halldorsdottir G; Andrésson T; Gurney ME; Singh J
Bioorg Med Chem Lett; 2009 Dec; 19(23):6797-800. PubMed ID: 19836233
[TBL] [Abstract][Full Text] [Related]
4. Novel methylene-linked heterocyclic EP1 receptor antagonists.
Hall A; Bit RA; Brown SH; Chowdhury A; Giblin GM; Hurst DN; Kilford IR; Lewell X; Naylor A; Scoccitti T
Bioorg Med Chem Lett; 2008 Mar; 18(5):1592-7. PubMed ID: 18262416
[TBL] [Abstract][Full Text] [Related]
5. Non-acidic pyrazole EP1 receptor antagonists with in vivo analgesic efficacy.
Hall A; Billinton A; Brown SH; Clayton NM; Chowdhury A; Giblin GM; Goldsmith P; Hayhow TG; Hurst DN; Kilford IR; Naylor A; Passingham B; Winyard L
Bioorg Med Chem Lett; 2008 Jun; 18(11):3392-9. PubMed ID: 18462938
[TBL] [Abstract][Full Text] [Related]
6. Discovery of GSK345931A: An EP(1) receptor antagonist with efficacy in preclinical models of inflammatory pain.
Hall A; Brown SH; Budd C; Clayton NM; Giblin GM; Goldsmith P; Hayhow TG; Hurst DN; Naylor A; Anthony Rawlings D; Scoccitti T; Wilson AW; Winchester WJ
Bioorg Med Chem Lett; 2009 Jan; 19(2):497-501. PubMed ID: 19036582
[TBL] [Abstract][Full Text] [Related]
7. Discovery of indole-containing tetracycles as a new scaffold for androgen receptor ligands.
Zhang X; Li X; Allan GF; Musto A; Lundeen SG; Sui Z
Bioorg Med Chem Lett; 2006 Jun; 16(12):3233-7. PubMed ID: 16603353
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel aminothiadiazole amides as selective EP(3) receptor antagonists.
Hilfiker MA; Wang N; Hou X; Du Z; Pullen MA; Nord M; Nagilla R; Fries HE; Wu CW; Sulpizio AC; Jaworski JP; Morrow D; Edwards RM; Jin J
Bioorg Med Chem Lett; 2009 Aug; 19(15):4292-5. PubMed ID: 19487124
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships of 1,5-biaryl pyrroles as EP1 receptor antagonists.
Hall A; Atkinson S; Brown SH; Chessell IP; Chowdhury A; Clayton NM; Coleman T; Giblin GM; Gleave RJ; Hammond B; Healy MP; Johnson MR; Michel AD; Naylor A; Novelli R; Spalding DJ; Tang SP
Bioorg Med Chem Lett; 2006 Jul; 16(14):3657-62. PubMed ID: 16697196
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships and pharmacokinetic parameters of quinoline acylsulfonamides as potent and selective antagonists of the EP(4) receptor.
Burch JD; Belley M; Fortin R; Deschênes D; Girard M; Colucci J; Farand J; Therien AG; Mathieu MC; Denis D; Vigneault E; Lévesque JF; Gagné S; Wrona M; Xu D; Clark P; Rowland S; Han Y
Bioorg Med Chem Lett; 2008 Mar; 18(6):2048-54. PubMed ID: 18291643
[TBL] [Abstract][Full Text] [Related]
11. Discovery of nonsteroidal glucocorticoid receptor ligands based on 6-indole-1,2,3,4-tetrahydroquinolines.
Roach SL; Higuchi RI; Adams ME; Liu Y; Karanewsky DS; Marschke KB; Mais DE; Miner JN; Zhi L
Bioorg Med Chem Lett; 2008 Jun; 18(12):3504-8. PubMed ID: 18513967
[TBL] [Abstract][Full Text] [Related]
12. EP1 antagonists for the treatment of inflammatory pain.
Hall A; Billinton A; Giblin GM
Curr Opin Drug Discov Devel; 2007 Sep; 10(5):597-612. PubMed ID: 17786859
[TBL] [Abstract][Full Text] [Related]
13. Discovery of new chemical leads for selective EP1 receptor antagonists.
Naganawa A; Saito T; Nagao Y; Egashira H; Iwahashi M; Kambe T; Koketsu M; Yamamoto H; Kobayashi M; Maruyama T; Ohuchida S; Nakai H; Kondo K; Toda M
Bioorg Med Chem; 2006 Aug; 14(16):5562-77. PubMed ID: 16697646
[TBL] [Abstract][Full Text] [Related]
14. 3,4-Disubstituted indole acylsulfonamides: a novel series of potent and selective human EP3 receptor antagonists.
Zhou N; Zeller W; Krohn M; Anderson H; Zhang J; Onua E; Kiselyov AS; Ramirez J; Halldorsdottir G; Andrésson T; Gurney ME; Singh J
Bioorg Med Chem Lett; 2009 Jan; 19(1):123-6. PubMed ID: 19022669
[TBL] [Abstract][Full Text] [Related]
15. 3-(2-Aminocarbonylphenyl)propanoic acid analogs as potent and selective EP3 receptor antagonists. Part 3: Synthesis, metabolic stability, and biological evaluation of optically active analogs.
Asada M; Obitsu T; Kinoshita A; Nagase T; Yoshida T; Yamaura Y; Takizawa H; Yoshikawa K; Sato K; Narita M; Nakai H; Toda M; Tobe Y
Bioorg Med Chem; 2010 May; 18(9):3212-23. PubMed ID: 20385498
[TBL] [Abstract][Full Text] [Related]
16. Identification of prostaglandin D2 receptor antagonists based on a tetrahydropyridoindole scaffold.
Beaulieu C; Guay D; Wang Z; Leblanc Y; Roy P; Dufresne C; Zamboni R; Berthelette C; Day S; Tsou N; Denis D; Greig G; Mathieu MC; O'Neill G
Bioorg Med Chem Lett; 2008 Apr; 18(8):2696-700. PubMed ID: 18359630
[TBL] [Abstract][Full Text] [Related]
17. 3-Acrylamide-4-aryloxyindoles: synthesis, biological evaluation and metabolic stability of potent and selective EP3 receptor antagonists.
Zhou N; Zeller W; Zhang J; Onua E; Kiselyov AS; Ramirez J; Palsdottir G; Halldorsdottir G; Andrésson T; Gurney ME; Singh J
Bioorg Med Chem Lett; 2009 Mar; 19(5):1528-31. PubMed ID: 19188065
[TBL] [Abstract][Full Text] [Related]
18. Identification and optimization of novel 1,3,4-oxadiazole EP1 receptor antagonists.
Hall A; Brown SH; Chowdhury A; Giblin GM; Gibson M; Healy MP; Livermore DG; Wilson RJ; Naylor A; Rawlings DA; Roman S; Ward E; Willay C
Bioorg Med Chem Lett; 2007 Aug; 17(16):4450-5. PubMed ID: 17574410
[TBL] [Abstract][Full Text] [Related]
19. 1,7-Disubstituted oxyindoles are potent and selective EP(3) receptor antagonists.
Zhou N; Polozov AM; O'Connell M; Burgeson J; Yu P; Zeller W; Zhang J; Onua E; Ramirez J; Palsdottir GA; Halldorsdottir GV; Andresson T; Kiselyov AS; Gurney M; Singh J
Bioorg Med Chem Lett; 2010 Apr; 20(8):2658-64. PubMed ID: 20303752
[TBL] [Abstract][Full Text] [Related]
20. Discovery of 4-[1-[([1-[4-(trifluoromethyl)benzyl]-1H-indol-7-yl]carbonyl)amino]cyclopropyl]benzoic acid (MF-766), a highly potent and selective EP4 antagonist for treating inflammatory pain.
Colucci J; Boyd M; Berthelette C; Chiasson JF; Wang Z; Ducharme Y; Friesen R; Wrona M; Levesque JF; Denis D; Mathieu MC; Stocco R; Therien AG; Clarke P; Rowland S; Xu D; Han Y
Bioorg Med Chem Lett; 2010 Jun; 20(12):3760-3. PubMed ID: 20471829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
